David Bennett - Ryman Healthcare Group Officer

RH7 Stock  EUR 2.55  0.04  1.54%   

Insider

David Bennett is Group Officer of Ryman Healthcare Limited
Phone64 3 366 4069
Webhttps://www.rymanhealthcare.co.nz

David Bennett Latest Insider Activity

Tracking and analyzing the buying and selling activities of David Bennett against Ryman Healthcare stock is an integral part of due diligence when investing in Ryman Healthcare. David Bennett insider activity provides valuable insight into whether Ryman Healthcare is net buyers or sellers over its current business cycle. Note, Ryman Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ryman Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Ryman Healthcare Management Efficiency

Ryman Healthcare's management efficiency ratios could be used to measure how well Ryman Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Fiona ChalmersComputershare Limited
N/A
Bryan HartinIridium Communications
59
Thaddeus WeedCogent Communications Holdings
62
Raymond KummerCogent Communications Holdings
74
Michael BrownComputershare Limited
N/A
Paul ConnComputershare Limited
N/A
Naz SarkarComputershare Limited
N/A
Andy MorrisGamma Communications plc
52
John ChangCogent Communications Holdings
51
Scott ScheimreifIridium Communications
54
Vincent TeissierCogent Communications Holdings
55
James BubeckCogent Communications Holdings
57
Kenneth LevyIridium Communications
N/A
Dominic HorsleyComputershare Limited
N/A
Timothy ONeillCogent Communications Holdings
67
Lucy NewcombeComputershare Limited
N/A
Chris WadeGamma Communications plc
N/A
Carlos LeiraComputershare Limited
N/A
David SchaefferCogent Communications Holdings
67
Matthew DeschIridium Communications
65
Suzanne McBrideIridium Communications
54
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. RYMAN HEALTHCARE operates under Long-Term Care Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5300 people. Ryman Healthcare Limited (RH7) is traded on Frankfurt Exchange in Germany and employs 6,800 people.

Management Performance

Ryman Healthcare Leadership Team

Elected by the shareholders, the Ryman Healthcare's board of directors comprises two types of representatives: Ryman Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryman. The board's role is to monitor Ryman Healthcare's management team and ensure that shareholders' interests are well served. Ryman Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryman Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
MaryAnne Stone, Chief Officer
Michelle Perkins, Investor Mang
Cheyne Chalmers, Chief Zealand
Chris BE, Chief Officer
David Bennett, Group Officer
Deborah Marris, G Sec
Marsha Cadman, Chief Officer
Cameron Holland, Chief Australia
Rick Davies, Chief Officer
Richard Umbers, Group Exec

Ryman Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ryman Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Ryman Stock

Ryman Healthcare financial ratios help investors to determine whether Ryman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.